Literature DB >> 7930202

Effect of physiologic and pharmacologic adrenergic stimulation on heart rate variability.

M W Ahmed1, A H Kadish, M A Parker, J J Goldberger.   

Abstract

OBJECTIVES: The aim of this study was to evaluate and compare the effects of physiologic and pharmacologic sympathetic stimulation on time and frequency domain indexes of heart rate variability.
BACKGROUND: Measurements of heart rate variability have been used as indexes of sympathetic tone. To date, the effects of circulating catecholamines on heart rate variability have not been evaluated.
METHODS: Fourteen normal subjects (eight men, six women, mean [+/- SD] age 28.5 +/- 4.8 years) were evaluated. Five-minute electrocardiographic recordings were obtained in triplicate after physiologic and pharmacologic sympathetic stimulation: during upright tilt, after maximal exercise, during epinephrine and isoproterenol infusions at 50 ng/kg body weight per min, during beta-adrenergic blockade and during combined beta-adrenergic and parasympathetic blockade.
RESULTS: Beta-adrenergic stimulation resulted in a significant decrease in time domain measures of heart rate variability. The frequency domain indexes showed variable responses, depending on the individual stimulus. Tilt caused an increase in low frequency power and in the ratio of low to high frequency power. These changes were not necessarily observed with other conditions of beta-adrenergic stimulation. Double blockade suppressed baseline heart rate variability, but beta-adrenergic blockade had no significant effect. Time domain measures of heart rate variability demonstrated excellent reproducibility over the three recordings, but the frequency domain variables demonstrated fair to excellent reproducibility.
CONCLUSIONS: These findings suggest that different modes of beta-adrenergic stimulation may result in divergent heart rate variability responses. Thus, current heart rate variability techniques cannot be used as general indexes of "sympathetic" tone. Studies utilizing heart rate variability to quantify sympathetic tone need to consider this.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930202     DOI: 10.1016/0735-1097(94)90874-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  Blunted heart rate response to vagal withdrawal in persons with tetraplegia.

Authors:  Jill M Wecht; Joseph P Weir; William A Bauman
Journal:  Clin Auton Res       Date:  2006-10-25       Impact factor: 4.435

Review 2.  Cardiac sympathetic innervation, from a different point of (re)view.

Authors:  Tania Zaglia; Marco Mongillo
Journal:  J Physiol       Date:  2017-06-15       Impact factor: 5.182

Review 3.  Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans.

Authors:  Jani Penttilä; Tom Kuusela; Harry Scheinin
Journal:  Eur J Clin Pharmacol       Date:  2005-08-30       Impact factor: 2.953

4.  Guanfacine alters the effect of stress and smoking on heart rate variability in regular daily smokers.

Authors:  Terril L Verplaetse; Philip H Smith; Kathryn M Z Smith; Lindsay M Oberleitner; Sherry A McKee
Journal:  Psychopharmacology (Berl)       Date:  2016-12-27       Impact factor: 4.530

Review 5.  Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes.

Authors:  David S Goldstein; Oladi Bentho; Mee-Yeong Park; Yehonatan Sharabi
Journal:  Exp Physiol       Date:  2011-09-02       Impact factor: 2.969

6.  Recovery of heart rate variability and ventricular repolarization indices following exercise.

Authors:  Marc K Lahiri; Alexandru Chicos; Dan Bergner; Jason Ng; Smirti Banthia; Norman C Wang; Haris Subačius; Alan H Kadish; Jeffrey J Goldberger
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

7.  The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance.

Authors:  George E Billman
Journal:  Front Physiol       Date:  2013-02-20       Impact factor: 4.566

8.  Heart rate variability in normal-weight patients with polycystic ovary syndrome.

Authors:  Celal Kilit; Türkan Paşalı Kilit
Journal:  Anatol J Cardiol       Date:  2017-03-09       Impact factor: 1.596

9.  Use of goat interleukin-6, cortisol, and some biomarkers to evaluate clinical suitability of two routes of ascorbic acid administration in transportation stress.

Authors:  K T Biobaku; T O Omobowale; Ahmed O Akeem; A Aremu; N Okwelum; A S Adah
Journal:  Vet World       Date:  2018-05-22

10.  Comparison of autonomic stress reactivity in young healthy versus aging subjects with heart disease.

Authors:  Nil Z Gurel; Andrew M Carek; Omer T Inan; Oleksiy Levantsevych; Naser Abdelhadi; Muhammad Hammadah; Wesley T O'Neal; Heval Kelli; Kobina Wilmot; Laura Ward; Steven Rhodes; Brad D Pearce; Puja K Mehta; Michael Kutner; Ernest Garcia; Arshed Quyyumi; Viola Vaccarino; Paolo Raggi; J Douglas Bremner; Amit J Shah
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.